从“小修小补”到全面进攻，艾迪药业已不满足于在国内抗HIV市场稳步追赶，以及在人源蛋白领域寻求第二增长曲线，而是试图通过加码全球临床研发，将触角延伸至美国等核心海外市场，完成从本土药企到全球玩家的身份跨越。
Opens in a new window
，这一点在safew官方下载中也有详细论述
There is currently no EU decision recognising Kenya as providing an adequate level of protection, but the EU and Kenya began a dialogue on the matter in May 2024. It is expected to take time before an agreement is in place.，推荐阅读Line官方版本下载获取更多信息
name: "support_agent",